Analysts expect Mineralys Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.70 M | 13.75 M | 14.89 M | 13.59 M | 50.33 M | 66.14 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.47 M | 12.69 M | 13.88 M | 12.71 M | 45.00 M | 61.86 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59 M | 13.22 M | 14.38 M | 13.15 M | 47.67 M | 64.00 M |
Analysts expect Mineralys Therapeutics, Inc. to report earnings per share of -0.58 for Q4 26, against a range of -0.61 to -0.55. The most recent reported quarter, Q3 26, came in at -0.64, a 21.6% miss against the -0.53 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.13 | -0.98 | -0.79 | -0.66 | -0.52 | -0.40 | -0.47 | -2.85 | -0.64 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.75 | -1.03 | -0.99 | -0.69 | -0.52 | -0.51 | -0.43 | -0.56 | -0.51 | -0.55 | -0.70 | -0.50 | 0.21 | -0.02 | -0.59 | -0.84 | 0.23 | |||||||||
| Low Estimate | -0.85 | -1.21 | -1.07 | -0.75 | -0.64 | -0.57 | -0.47 | -0.60 | -0.55 | -0.61 | -0.74 | -0.60 | 0.19 | -0.02 | -0.63 | -0.96 | 0.21 | |||||||||
| Consensus Estimate | -0.80 | -1.12 | -1.03 | -0.72 | -0.58 | -0.54 | -0.45 | -0.58 | -0.53 | -0.58 | -0.72 | -0.55 | 0.20 | -0.02 | -0.61 | -0.90 | 0.22 |
Pull Wall Street consensus for Mineralys Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MLYS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MLYS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MLYS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();